newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals PLC Announces Hemo-CAR-T partnership with WuXi ATU

Partnership with WuXi Advanced Therapies to manufacture lentiviral vectors for phase I trial of cutting edge HEMO-CAR-T programme LONDON, UK / ACCESSWIRE / December 20, 2021 / Hemogenyx Pharmaceuticals will leverage WuXi Advanced Therapies' ("WuXi ATU")